Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$14.90
0.382.62%
Last update: Jun 4, 2:23 PM
Mesoblast Ltd Analyst Ratings
MESONASDAQ
Mesoblast Analyst Ratings and Price Targets | NASDAQ:MESO | Benzinga
Mesoblast Ltd has a consensus price target of $12.5 based on the ratings of 6 analysts. The high is $24 issued by Piper Sandler on February 7, 2025. The low is $1.5 issued by Chardan Capital on August 4, 2023. The 3 most-recent analyst ratings were released by Piper Sandler, Piper Sandler, and Maxim Group on February 7, 2025, December 19, 2024, and September 24, 2024, respectively. With an average price target of $17 between Piper Sandler, Piper Sandler, and Maxim Group, there's an implied 14.09% upside for Mesoblast Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Maxim Group
Chardan Capital
1calculated from analyst ratings
Analyst Ratings for Mesoblast
Loading calendar...
FAQ
What is the target price for Mesoblast (MESO) stock?
The latest price target for Mesoblast (NASDAQ:MESO) was reported by Jefferies on November 25, 2025. The analyst firm set a price target for $0.00 expecting MESO to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Mesoblast (MESO)?
The latest analyst rating for Mesoblast (NASDAQ:MESO) was provided by Jefferies, and Mesoblast upgraded their buy rating.
When was the last upgrade for Mesoblast (MESO)?
The last upgrade for Mesoblast Ltd happened on November 25, 2025 when Jefferies raised their price target to N/A. Jefferies previously had a hold for Mesoblast Ltd.
When was the last downgrade for Mesoblast (MESO)?
The last downgrade for Mesoblast Ltd happened on July 18, 2025 when Jefferies changed their price target from N/A to N/A for Mesoblast Ltd.
When is the next analyst rating going to be posted or updated for Mesoblast (MESO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mesoblast, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mesoblast was filed on November 25, 2025 so you should expect the next rating to be made available sometime around November 25, 2026.
Is the Analyst Rating Mesoblast (MESO) correct?
While ratings are subjective and will change, the latest Mesoblast (MESO) rating was a upgraded with a price target of $0.00 to $0.00. The current price Mesoblast (MESO) is trading at is $14.90, which is out of the analyst’s predicted range.
